Hemodynamics, fluids & transfusion

Hemodynamic and neurological presentations of invasive meningococcal disease in adults: a nationwide study across 100+ French intensive care unit (ICUs) : The RETRO-MENINGO study

Intensive Care MedPublished Retrospective cohort study

Main finding · Day-60 mortalityResult — go to the resultAdjusted odds ratio 4.33 95% CI 2.26–8.62

Authors' conclusion

Neurological and hemodynamic presentation of IMD are clinically and prognostically distinct.

Study context

Population
Adults (≥ 18 years) admitted to the ICU with microbiologically confirmed invasive meningococcal disease, 102 French ICUs, 2016–2024
Participants
654 adults · 102 French ICUs
Exposure
Hemodynamic vs neurological presentation of invasive meningococcal disease (IMD) at ICU admission
  • Hemodynamicn = 247
  • Neurologicaln = 407reference
Outcome
Mortality in each presentation
Follow-up
Day 60
Methodological detailsnationwide, multicentre
  • Nationwide
  • Multicentre

Main finding

Day-60 mortality

Adjusted odds ratio

4.33

95% CI 2.26–8.62

P < 0.001

By group

Hemodynamic vs Neurological
aOR 4.33 (95% CI 2.26–8.62); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

Baseline characteristics

Age, Hemodynamic vs Neurological (years)
39.0 vs. 30.0; p = 0.001
Immunosuppression
17.0% vs. 7.1%; p < 0.001
Purpuric rash
55.9% vs. 43.7%; p = 0.003
Time to ICU admission (days)
1 vs. 2; p = 0.001
Bacteremia
83.8% vs. 35.6%; p < 0.001
Serogroup B predominant in neurological, W135 more common in hemodynamic presentation
More organ support (vasopressors, invasive mechanical ventilation, transfusions, RRT) in hemodynamic presentation

Other independent factors for day-60 mortality

Absence of comorbidities, aOR
2.21 (1.19-4.23); p = 0.014 (95% CI)
Age > 35 years, aOR
3.65 (1.73-6.07); p < 0.001 (95% CI)
Arterial lactate > 5 mmol/L, aOR
2.60 (1.43-4.77); p = 0.002 (95% CI)
Symptom onset < 24 h, aOR
1.90 (1.00-3.55); p = 0.040 (95% CI)
Early parenteral third-generation cephalosporin before ICU admission (protective), aOR
0.31 (0.18-0.55); p < 0.001 (95% CI)

Original publication

Hemodynamic and neurological presentations of invasive meningococcal disease in adults: a nationwide study across 100+ French ICUs : The RETRO-MENINGO study. Intensive Care Med. Published 12 August 2025. doi:10.1007/s00134-025-08043-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.